We have identified a request from the clinical community for increasing the reliability in musculo-skeletal treatments. In addition, the solution we propose, given its technical and economic characteristics, covers a wide target audience, as is the case of small and medium-sized clinics. In our market study, only in our national market (Spain), we have a real target population of 85,000 health centers, without having medical centers or polyclinics. Accessing the 0.5% of this target population through the software licensing of ADiBAS Motion we estimate an income of 1.8M €. These revenues do not take into account other services that will be offered around the software, or as a complement. Given our experience in marketing ADiBAS® Posture, these services mainly rely mainly on technical and clinical training, support, maintenance and installation. We analysed the market for our product for studying a possible implementation in other countries. We are focused on the European market, mainly in France, Germany and Italy because we have established agreements with distributors with our first product, ADiBAS® Posture, and we see a good acceptance and 36 growth in sales. We expect to enter, and consolidate, in the market of South America (Argentina, Colombia, Mexico and Chile), where there is a high emergence of health professionals and a great increase in research studies, receptive to using technology to support the diagnosis. We consider entry into these markets key given their potential growth rate.